Transdermal penetration enhancers: Applications, limitations, and potential

被引：203

作者：

Finnin, BC ^{[1
]}

Morgan, TM ^{[1
]}

机构：

[1] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut, Parkville, Vic 3052, Australia

来源：

关键词：

D O I：

10.1021/js990154g

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：955 / 958

页数：4

共 69 条

[1]

BAKALOVA MV, 1997, PERSPECTIVES PERCU A, V5, P78

[2]

Barry, 1983, DERMATOLOGICAL FORMU

[3] Reflections on transdermal drug delivery [J].

Barry, BW .

PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (02) :41-43

[4]

BARRY BW, 1985, PERCUTANEOUS ABSORPT, P492

[5]

BARRY BW, 1991, IN VITRO PERCUTANEOU, P165

[6]

Barry BW, 1993, TOPICAL DRUG BIOAVAI, P268

BERNER, B ;

MAZZENGA, GC ;

OTTE, JH ;

STEFFENS, RJ ;

JUANG, RH ;

EBERT, CD .

[8]

BERNER B, 1987, TRANSDERMAL DELIVERY, V2, P44

[9]

Bronaugh R, 1999, Percutaneous absorption : drugs-cosmetics-mechanisms-methodology

[10]

BURRIS JF, 1991, AM J MED A, V1, pS22